 您的位置：对照品 > 对照品 > 国家对照品 > |
|
|
|
| 产品基本信息 |
|
| 产品编号：H325800 |
| 产品名称：Higenamine Hydrobromide Salt |
| 产品CAS：63604-85-3 |
| 规格含量：250mg |
| 产品价格：面议 |
| 联系我们: |
 |
|
 |
|
|
| 产品详细介绍 |
| 标准品编号: |
H325800 |
| 名称: |
Higenamine Hydrobromide Salt |
| 别名: |
1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6,7-isoquinolinediol Hydrobromide; (+/-)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6,7-isoquinolinediol Hydrobromide; (+/-)-O-demethyl-Coclaurine Hydrobromide; (RS)-Norcoclaurine Hydrobromide; (+/-)-Demethylcoclaurine Hydrobromide; (+/-)-Norcoclaurine Hydrobromide; (+/-)-O-Demethylcoclaurine Hydrobromide; dl-Demethylcoclaurine Hydrobromide |
| CAS号: |
63604-85-3 |
| 参考CAS号: |
Free Base: 5843-65-2 / HCl: 11041-94-4 |
| 分子式: |
C₁₆H₁₈BrNO₃ |
| 外观: |
白色至白色固体 |
| 熔点: |
>245°C (dec.) |
| 分子量: |
352.22 |
| 储存: |
冰箱 |
| 溶解度: |
DMSO (Slightly), Methanol (Slightly) |
| 种类: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: |
Higenamine acts through inhibition of middle cerebral artery occlusion (MCAO)-mediated HMGB1 release in vivo. Useful towards ischemic injuries. |
| 参考文献 |
|
|
|
|
|
|
|
|
